Elizabeth A. Olek

Insider Reports History

Entity
Individual
Location
C/O Achillion Pharmaceuticals, Inc., 300 George Street, New Haven, CT
Signature
/s/ Allison Frisbee, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Elizabeth A. Olek:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Kronos Bio, Inc. SR VP, CLINICAL SCIENCE Common Stock 193K $204K $1.05 Feb 21, 2024 Direct

Insider Reports Filed by Elizabeth A. Olek

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KRON Kronos Bio, Inc. Feb 21, 2024 1 -$7.77K 4 Feb 23, 2024 SR VP, CLINICAL SCIENCE
KRON Kronos Bio, Inc. Feb 16, 2024 0 $0 3 Feb 23, 2024 SR VP, CLINICAL SCIENCE